Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
15.90
-0.16 (-1.00%)
At close: Feb 26, 2026, 4:00 PM EST
15.89
-0.01 (-0.06%)
After-hours: Feb 26, 2026, 5:36 PM EST
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $660.17 million as of February 26, 2026. Its market cap has increased by 283.38% in one year.
Market Cap
660.17M
Enterprise Value
496.91M
1-Year Change
283.38%
Ranking
Category
Stock Price
$15.90
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $660.17M, a decrease of -49.18%. That is a compound annual growth rate of -12.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 25, 2026 | 666.81M | 31.66% |
| Dec 31, 2025 | 506.46M | 266.35% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Replimune Group | 692.78M |
| ProKidney | 649.80M |
| enGene Holdings | 647.74M |
| Jade Biosciences | 645.90M |
| Lexicon Pharmaceuticals | 644.90M |
| Alpha Tau Medical | 623.28M |
| Rigel Pharmaceuticals | 621.87M |
| LB Pharmaceuticals | 607.43M |